In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata

Anaerobe

Volumn 34, Issue , 2015, Pages 132-138

  Chew, Shu Yih ^a   Cheah, Yoke Kqueen ^a   Seow, Heng Fong ^a   Sandai, Doblin ^b   Than, Leslie Thian Lung ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

Author keywords

Anti biofilm; Candida glabrata; Lactobacillus reuteri RC 14; Lactobacillus rhamnosus GR 1; Probiotic; Vulvovaginal candidiasis

Indexed keywords

LACTIC ACID; PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; BIOFILM; CANDIDA GLABRATA; CONTROLLED STUDY; DOWN REGULATION; EPA6 GENE; FUNGAL GENE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE EXPRESSION; GROWTH INHIBITION; IN VITRO STUDY; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; VAGINA CANDIDIASIS; YAK1 GENE; YEAST CELL; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; ORGANISMAL INTERACTION; PHYSIOLOGY;

CANDIDA GLABRATA; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS;

BIOFILMS; CANDIDA GLABRATA; GENE EXPRESSION PROFILING; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MICROBIAL INTERACTIONS; MICROSCOPY, ELECTRON, SCANNING; PROBIOTICS;

EID: 84936854774     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.05.009     Document Type: Article

References (33)

1. Fidel P.L. History and update on host defense against vaginal candidiasis. Am. J. Reprod. Immunol. 2007, 57(1):2-12.
2. Eckert L.O., Hawes S.E., Stevens C.E., Koutsky L.A., Eschenbach D.A., Holmes K.K. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet. Gynecol. 1998, 92(5):757-765.
3. Sobel J.D., Faro S., Force R.W., Foxman B., Ledger W.J., Nyirjesy P.R., Reed B.D., Summers P.R. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol. 1998, 178(2):203-211.
4. Sobel J.D. Vulvovaginal candidosis. Lancet 2007, 369(9577):1961-1971.
5. Goswami R., Dadhwal V., Tejaswi S., Datta K., Paul A., Haricharan R.N., Banerjee U., Kochupillai N.P. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status. J.Infect. 2000, 41(2):162-166.
6. Goswami D., Goswami R., Banerjee U., Dadhwal V., Miglani S., Lattif A.A., Kochupillai N. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. J.Infect. 2006, 52(2):111-117.
7. Foxman B., Barlow R., D'arcy H., Gillespie B., Sobel J.D. Candida vaginitis: self-reported incidence and associated costs. Sex. Transm. Dis. 2000, 27(4):230-235.
8. Harriott M.M., Lilly E.A., Rodriguez T.E., Fidel P.L., Noverr M.C. Candida albicans forms biofilms on the vaginal mucosa. Microbiology 2010, 156(12):3635-3644.
9. Douglas L.J. Candida biofilms and their role in infection. Trends Microbiol. 2003, 11(1):30-36.
10. Davies D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2003, 2(2):114-122.
11. Ramage G., Rajendran R., Sherry L., Williams C. Fungal biofilm resistance. Int. J. Microbiol. 2012, 528521. 10.1155/2012/528521.
12. Lewis K. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 2001, 45(4):999-1007.
13. Silva S., Henriques M., Martins A., Oliveira R., Williams D., Azeredo J. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med. Mycol. 2009, 47(7):681-689.
14. Reid G., Jass J., Sebulsky M.T., McCormick J.K. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev. 2003, 16(4):658-672.
15. Sanders M.E. Probiotics: definition, sources, selection, and uses. Clin. Infect. Dis. 2008, 46(2):58-61.
16. Reid G., Charbonneau D., Erb J., Kochanowski B., Beuerman D., Poehner R., Bruce A.W. Oral use of Lactobacillus rhamnosus GR-1 and L.fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 2003, 35(2):131-134.
17. Köhler G.A., Assefa S., Reid G. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect. Dis. Obstet. Gynecol. 2012, 636474. 10.1155/2012/636474.
18. Martinez R.C., Franceschini S.A., Patta M.C., Quintana S.M., Candido R.C., Ferreira J.C., De Martinis E.C., Reid G. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett. Appl. Microbiol. 2009, 48(3):269-274.
19. Martinez R.C., Franceschini S.A., Patta M.C., Quintana S.M., Gomes B.C., De Martinis E.C., Reid G. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can. J. Microbiol. 2009, 55(2):133-138.
20. Cianci A., Giordano R., Delia A., Grasso E., Amodeo A., De Leo V., Caccamo F. Efficacy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses. Minerva Ginecol. 2008, 60(5):369-376.
21. Fujita S.I., Senda Y., Nakaguchi S., Hashimoto T. Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains. J.Clin. Microbiol. 2001, 39(10):3617-3622.
22. Collart M.A., Oliviero S. Preparation of yeast RNA. Current Protocols in Molecular Biology 1993, John Wiley & Sons, Inc, Hoboken, NJ.
23. Pfaffl M.W. Anew mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29(9):e45.
24. Gil N.F., Martinez R.C.R., Gomes B.C., Nomizo A., De Martinis E.C.P. Vaginal lactobacilli as potential probiotics against Candida spp. Braz. J. Microbiol. 2010, 41(1):6-14.
25. Cribby S., Taylor M., Reid G. Vaginal microbiota and the use of probiotics. Interdiscip. Perspect. Infect. Dis. 2008, 256490. 10.1155/2008/256490.
26. Reid G., Cuperus P.L., Bruce A.W., van der Mei H.C., Tomeczek L., Khoury A.H., Busscher H.J. Comparison of contact angles and adhesion to hexadecane of urogenital, dairy, and poultry lactobacilli: effect of serial culture passages. Appl. Environ. Microbiol. 1992, 58(5):1549-1553.
27. Velraeds M.M., van der Mei H.C., Reid G., Busscher H.J. Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl. Environ. Microbiol. 1996, 62(6):1958-1963.
28. Tahmourespour A., Salehi R., Kasra Kermanshahi R. Lactobacillus acidophilus-derived biosurfactant effect on GTFB and GTFC expression level in Streptococcus mutans biofilm cells. Braz J. Microbiol. 2011, 42(1):330-339.
29. Arias-Moliz M.T., Baca P., Ordóñez-Becerra S., González-Rodríguez M.P., Ferrer-Luque C.M. Eradication of enterococci biofilms by lactic acid alone and combined with chlorhexidine and cetrimide. Med. Oral Patol. Oral Cir. Bucal 2012, 17(5):e902-e906.
30. Al-Mathkhury H.J., Ali A.S., Ghafil J.A. Antagonistic effect of bacteriocin against urinary catheter associated Pseudomonas aeruginosa biofilm. N.Am. J. Med. Sci. 2011, 3(8):367-370.
31. Iraqui I., Garcia-Sanchez S., Aubert S., Dromer F., Ghigo J.M., d'Enfert C., Janbon G. The Yak1p kinase controls expression of adhesins and biofilm formation in Candida glabrata in a Sir4p-dependent pathway. Mol. Microbiol. 2005, 55(4):1259-1271.
32. Kucharíková S., Tournu H., Lagrou K., Van Dijck P., Bujdáková H. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J.Med. Microbiol. 2011, 60(9):1261-1269.
33. Riera M., Mogensen E., d'Enfert C., Janbon G. New regulators of biofilm development in Candida glabrata. Res. Microbiol. 2012, 163(4):297-307.